Spruce Biosciences is based in South San Francisco. It has raised $88M in total funding. Latest round: Series B.
Spruce Biosciences is based in South San Francisco. Spruce Biosciences has raised $88M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2020. The round record for Spruce Biosciences runs through 2020; nothing later has been disclosed. Investors on record include Omega Funds, Abingworth Bioventures, Novo Holdings, RiverVest Venture Partners, HealthCap, Rock Springs Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
Totals shown for Spruce Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in South San Francisco and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026